CAPLACIZUMAB is used for treatment of?
CAPLACIZUMAB: a. It is a Von - Willebrand factor (vWF) directed antibody fragment b. Target the A1 - domain of vWF, and inhibits the interaction between vWF and platelets, thereby reducing both vWF - mediated platelet adhesion and platelet consumption. c. Used for treatment of acquired Thrombotic Thrombocytopenic Purpura (aTTP)
Hematology
Acquired Thrombotic Thrombocytopenic Purpura (aTTP)
Plaque Psoriasis
Breast cancer
Bladder cancer
Acquired Thrombotic Thrombocytopenic Purpura (aTTP)